AU2001279709A1 - Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia - Google Patents

Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia

Info

Publication number
AU2001279709A1
AU2001279709A1 AU2001279709A AU7970901A AU2001279709A1 AU 2001279709 A1 AU2001279709 A1 AU 2001279709A1 AU 2001279709 A AU2001279709 A AU 2001279709A AU 7970901 A AU7970901 A AU 7970901A AU 2001279709 A1 AU2001279709 A1 AU 2001279709A1
Authority
AU
Australia
Prior art keywords
preventing
pyrimidine derivatives
treating cerebral
cerebral ischaemia
ischaemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001279709A
Inventor
Berthold Behl
Francisco Javier Garcia-Ladona
Kurt Schellhaas
Gerd Steiner
Laszlo Szabo
Liliane Unger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Publication of AU2001279709A1 publication Critical patent/AU2001279709A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001279709A 2000-07-03 2001-07-02 Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia Abandoned AU2001279709A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10031390A DE10031390A1 (en) 2000-07-03 2000-07-03 Pyrimidine derivatives and their use for the prophylaxis and therapy of cerebral ischemia
DE10031390 2000-07-03
PCT/EP2001/007569 WO2002002568A1 (en) 2000-07-03 2001-07-02 Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia

Publications (1)

Publication Number Publication Date
AU2001279709A1 true AU2001279709A1 (en) 2002-01-14

Family

ID=7647039

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001279709A Abandoned AU2001279709A1 (en) 2000-07-03 2001-07-02 Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia

Country Status (4)

Country Link
AR (1) AR028776A1 (en)
AU (1) AU2001279709A1 (en)
DE (1) DE10031390A1 (en)
WO (1) WO2002002568A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI417095B (en) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
US9114138B2 (en) 2007-09-14 2015-08-25 Janssen Pharmaceuticals, Inc. 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones
WO2010025890A1 (en) 2008-09-02 2010-03-11 Ortho-Mcneil-Janssen Pharmaceuticals, Inc 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
CN102316735A (en) * 2008-12-23 2012-01-11 哈佛大学校长及研究员协会 The micromolecular inhibitor of gangrenosum acne apoptosis
MX2011011962A (en) 2009-05-12 2012-02-28 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors.
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
SG10201402250TA (en) 2009-05-12 2014-07-30 Janssen Pharmaceuticals Inc 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
WO2012062750A1 (en) 2010-11-08 2012-05-18 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
EP2643320B1 (en) 2010-11-08 2015-03-04 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
ES2552879T3 (en) 2010-11-08 2015-12-02 Janssen Pharmaceuticals, Inc. 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US9725452B2 (en) 2013-03-15 2017-08-08 Presidents And Fellows Of Harvard College Substituted indoles and pyrroles as RIP kinase inhibitors
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
EA201891617A3 (en) 2014-01-21 2019-04-30 Янссен Фармацевтика Нв COMBINATIONS CONTAINING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR 2 SUBTIPES AND THEIR APPLICATION
HUE053734T2 (en) 2014-01-21 2021-07-28 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators of metabotropic glutamatergic receptor subtype 2 and their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810748D0 (en) * 1988-05-06 1988-06-08 Beecham Wuelfing Gmbh & Co Kg Novel treatment
DE19636769A1 (en) * 1996-09-10 1998-03-12 Basf Ag 3-Substituted pyrido [4 ', 3': 4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use
DE19900545A1 (en) * 1999-01-11 2000-07-13 Basf Ag Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia

Also Published As

Publication number Publication date
DE10031390A1 (en) 2002-01-17
WO2002002568A1 (en) 2002-01-10
AR028776A1 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
HK1053124A1 (en) Substituted quinazoline derivatives and their use as inhibitors
AU2002221047A1 (en) Quinazolinone derivatives
AU7860901A (en) Quinazoline derivatives
AU2001279709A1 (en) Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia
IL147924A0 (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
HK1054940A1 (en) Pyrimidine derivatives
AU1041802A (en) Tetrahydro-heterocycloazepinyl pyrimidine derivatives
IL185461A0 (en) Pyrimidine compounds and their use
AU2002212436A1 (en) Quinazoline derivatives
HK1078079A1 (en) Pyrimidine derivatives
AU2001292137A1 (en) Quinazoline derivatives
AU2433800A (en) Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
AU7271600A (en) Quinazolinone and azaquinazolinone derivatives
AU2685201A (en) S-triazine derivatives and their use as uv filters
AU4501199A (en) 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
AU2002216650A1 (en) Triazine derivatives as lpaat-b inhibitors and uses thereof
AU2001262149A1 (en) 2-(indanylamino)pyrimidone and 2-(tetrahydronaphthalenylamino)pyrimidone derivatives
AU2001218024A1 (en) Methods for treating and preventing alopecia
AU2001276375A1 (en) Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia
AU2694200A (en) Itchiness-relieving agents and itchiness-relieving effect potentiators
AU2001284485A1 (en) Adenosine derivatives and use thereof
AU2001287578A1 (en) Substituted thienopyrimidine derivatives and the use thereof for the prophylaxisand therapy of cerebral ischaemia
GB0030989D0 (en) Quinazoline derivatives
GB0015376D0 (en) Quinazoline derivatives